Chie Nakashima

832 total citations
43 papers, 607 citations indexed

About

Chie Nakashima is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chie Nakashima has authored 43 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Chie Nakashima's work include Cancer, Hypoxia, and Metabolism (9 papers), RNA modifications and cancer (5 papers) and Mitochondrial Function and Pathology (4 papers). Chie Nakashima is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), RNA modifications and cancer (5 papers) and Mitochondrial Function and Pathology (4 papers). Chie Nakashima collaborates with scholars based in Japan, China and India. Chie Nakashima's co-authors include Hiroki Kuniyasu, Tadaaki Kirita, Tomonori Sasahira, Rina Fujiwara‐Tani, Hitoshi Ohmori, Takamitsu Sasaki, Shingo Kishi, Kiyomu Fujii, Yukiko Nishiguchi and Isao Kawahara and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

Chie Nakashima

41 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chie Nakashima Japan 17 348 215 143 81 54 43 607
James V. Michael United States 13 320 0.9× 126 0.6× 140 1.0× 54 0.7× 83 1.5× 22 585
Suk‐young Lee South Korea 16 395 1.1× 148 0.7× 216 1.5× 111 1.4× 60 1.1× 43 719
M. Val Toledo-Lobo Spain 13 320 0.9× 135 0.6× 117 0.8× 60 0.7× 53 1.0× 31 531
Ming Ma China 14 289 0.8× 163 0.8× 127 0.9× 59 0.7× 100 1.9× 32 530
Yufan Zheng China 13 312 0.9× 133 0.6× 77 0.5× 101 1.2× 57 1.1× 24 518
Zhimin Liu China 15 357 1.0× 213 1.0× 241 1.7× 68 0.8× 100 1.9× 32 741
Feihu Bai China 17 419 1.2× 200 0.9× 177 1.2× 86 1.1× 54 1.0× 48 694

Countries citing papers authored by Chie Nakashima

Since Specialization
Citations

This map shows the geographic impact of Chie Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Nakashima more than expected).

Fields of papers citing papers by Chie Nakashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Nakashima. The network helps show where Chie Nakashima may publish in the future.

Co-authorship network of co-authors of Chie Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Nakashima. A scholar is included among the top collaborators of Chie Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Nakashima. Chie Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujiwara‐Tani, Rina, Chie Nakashima, Hitoshi Ohmori, et al.. (2025). Significance of Malic Enzyme 1 in Cancer: A Review. Current Issues in Molecular Biology. 47(2). 83–83. 1 indexed citations
2.
Fujiwara‐Tani, Rina, Takuya Mori, Isao Kawahara, et al.. (2024). Effects of Antioxidant Amino Acids on Cancer Sarcopenia. International Journal of Molecular Sciences. 26(1). 272–272.
3.
Luo, Yi, Rina Fujiwara‐Tani, Isao Kawahara, et al.. (2024). Cancerous Conditions Accelerate the Aging of Skeletal Muscle via Mitochondrial DNA Damage. International Journal of Molecular Sciences. 25(13). 7060–7060.
4.
Fujii, Kiyomu, Rina Fujiwara‐Tani, Hitoshi Ohmori, et al.. (2024). Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene. International Journal of Molecular Sciences. 25(5). 3015–3015. 2 indexed citations
5.
Nishida, Ryoichi, Yoshihiro Miyagawa, Kei Goto, et al.. (2024). Differential Effects of Three Medium-Chain Fatty Acids on Mitochondrial Quality Control and Skeletal Muscle Maturation. Antioxidants. 13(7). 821–821. 4 indexed citations
6.
Kishi, Shingo, Shiori Mori, Rina Fujiwara‐Tani, et al.. (2022). Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. International Journal of Molecular Sciences. 23(7). 4002–4002. 18 indexed citations
7.
Kishi, Shingo, Yukiko Nishiguchi, Kanya Honoki, et al.. (2021). Role of Glycated High Mobility Group Box-1 in Gastric Cancer. International Journal of Molecular Sciences. 22(10). 5185–5185. 13 indexed citations
8.
Ueda, N., et al.. (2021). Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer. Journal of Bone and Mineral Metabolism. 39(4). 623–630. 17 indexed citations
9.
10.
Mori, Takuya, Yoshihiro Miyagawa, Rina Fujiwara‐Tani, et al.. (2020). Combined administration of lauric acid and glucose improved cancer‐derived cardiac atrophy in a mouse cachexia model. Cancer Science. 111(12). 4605–4615. 23 indexed citations
11.
Fujiwara‐Tani, Rina, Takamitsu Sasaki, Hitoshi Ohmori, et al.. (2019). Concurrent Expression of CD47 and CD44 in Colorectal Cancer Promotes Malignancy. Pathobiology. 86(4). 182–189. 29 indexed citations
12.
Sasahira, Tomonori, et al.. (2019). The Oncogenic Activity of miR-29b-1-5p Induces the Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Journal of Clinical Medicine. 8(2). 273–273. 26 indexed citations
13.
Sasahira, Tomonori, et al.. (2018). NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 144(5). 875–882. 11 indexed citations
14.
Shimomura, Hiroyuki, et al.. (2018). Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma. Pathology. 50(6). 642–647. 14 indexed citations
15.
Sasahira, Tomonori, et al.. (2017). Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma. Journal of Clinical Pathology. 71(5). 436–441. 8 indexed citations
16.
Kusuoka, Osamu, Rina Fujiwara‐Tani, Chie Nakashima, et al.. (2017). Intermittent calorie restriction enhances epithelial-mesenchymal transition through the alteration of energy metabolism in a mouse tumor model. International Journal of Oncology. 52(2). 413–423. 16 indexed citations
17.
Sugiura, Tsutomu, Kazuhiko Yamamoto, Chie Nakashima, et al.. (2016). Chronic Maxillary Sinusitis Caused by Denture Lining Material. The Open Dentistry Journal. 10(1). 261–267. 4 indexed citations
18.
Sasahira, Tomonori, Miyako Kurihara, Chie Nakashima, Tadaaki Kirita, & Hiroki Kuniyasu. (2016). LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration. British Journal of Cancer. 115(1). 52–58. 24 indexed citations
19.
Nagaosa, Kaz, et al.. (2009). Immune response to bacteria in seminiferous epithelium. Reproduction. 137(5). 879–888. 16 indexed citations
20.
Nakashima, Chie, et al.. (2005). Studies on Structure of Poly(.EPSILON.-L-lysine) Spherulite Grown from Solution. Sen i Gakkaishi. 61(3). 61–66. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026